Trial ID or NCT#





The objectives of this study are to assess the safety of azficel-T treatment for dysphonia related to vocal fold function and to evaluate the efficacy of azficel-T for the treatment of dysphonia related to vocal fold function.

Official Title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Edward J. Damrose, MD, FACS
Otolaryngologist, Head and neck surgical oncologist, Surgical oncologist, Head and neck surgeon, Laryngologist
Professor of Otolaryngology - Head and Neck Surgery (Laryngology) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.


Edward J Damrose, MD
(650) 725-6500